Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

NOAH clarifies critically important antibiotics
Antibiotics
"All classes of antibiotics, whether critically important or not, should be used responsibly" - Donal Murphy, NOAH.
Document divides antimicrobials into risk categories

A document to clarify which antibiotics should be considered as critically important has been published by the National Office of Animal Health (NOAH).

The document comes after an assessment by the European Medicines Agency (EMA) and aims to clear up any confusion about which antibiotics should be considered in this group.

Carried out by the Antimicrobial Advice Ad Hoc Expert Group (AMEG), the work has resulted in the further categorisation of critically important antibiotics (CIAs) into risk categories.

Category one contains antimicrobials that are considered a low or limited risk to public health. It includes macrolides, certain penicillins and tetracyclines. NOAH states that these ‘should be used with current responsible use practices to keep their risk low’.

Category two contains antimicrobials that are considered a high risk to public health. This includes fluroquinolones, 3rd and 4th generation cephalosporins and colistin. NOAH adds that these antimicrobials ‘should only be used when there are no alternative antimicrobials authorised for the respected target species and indication’.

“NOAH believes the classification and use of antibiotics in veterinary medicine should be driven and guided by the regulators, who are independent and make science based decisions and recommendations,” said Donal Murphy, head of technical and regulatory affairs at NOAH.

“Of course, all classes of antibiotics, whether critically important or not, should be used responsibly and guided by the principle outlined by the Responsible Use of Medicines in Agriculture Alliance (RUMA) who state they should be used ‘as little as possible but as much as necessary’.

“The use of these important products in this manner can ensure that the availability and efficacy of antibiotics can be maintained to ensure animal health and welfare in the future,” he adds.

To view the document and other NOAH briefing documents on antibiotics visit noah.co.uk.

Become a member or log in to add this story to your CPD history

RUMA CA&E extends survey deadline

News Story 1
 RUMA CA&E has extended the deadline for its online survey into vaccine availability.

Vets, SQPs, retailers and wholesalers will now have until Friday, 26 September at 5pm to submit their response.

The survey aims to further understanding into the vaccine supply challenges faced by the sector. It will also consider the short and long term impacts of disruption issues.

Insights are anonymous, and will be shared with industry stakeholders and government bodies.

The survey can be accessed here

Click here for more...
News Shorts
Dechra launches checklist for veterinary sustainability

Global animal health specialist Dechra has announced the world's first Veterinary Green Theatre Checklist (VGTC) to help make surgery more sustainable.

Endorsed by leading veterinary organisations, including the BEVA, BVNA and RCVS Knowledge, the checklist is designed to reduce the environmental footprint of veterinary care, while supporting better animal health outcomes.

The checklist was launched at the World Congress of Veterinary Anaesthesia and Analgesia in Paris and will be followed by an internal training and awareness campaign. For more information, visit dechra.com